Indication
Allogeneic Hematopoietic Transplantation
1 clinical trial
1 drug
Clinical trial
Evaluation of the Influence of Timing of Post-transplant Cyclophosphamide in Allogeneic Haematopoietic Stem Cell Transplant Patients.Status: Recruiting, Estimated PCD: 2023-10-01
Drug
cyclophosphamide